Brief: Rua Bioscience Expect Revenue From Customers In Fy25 Will Be Significantly Higher
Aug 29 (Reuters) - Rua Bioscience Ltd RUA.NZ :
* EXPECT REVENUE FROM CUSTOMERS IN FY25 WILL BE
SIGNIFICANTLY
HIGHER THAN FY24
Further company coverage: RUA.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Partners With Curaleaf Laboratories For UK Distribution
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth